News & Events
EntroGen Newsletter
Receive quarterly updates on EntroGen news and products.
News & Press Releases
USC and EntroGen to study clinical utility of EntroGen’s liquid biopsy solutions for lung cancer
Today EntroGen Inc. announced that it has entered into a clinical collaboration with University of Southern California Norris Comprehensive Cancer Center to conduct an observational study to determine the clinical utility of EntroGen’s liquid biopsy solutions for lung cancer patients.
EntroGen announces CE-IVD marking of its BRCA Complete™ BRCA1/BRCA2 sequencing kit
Today EntroGen Inc. announced CE-IVD marking of its BRCA Complete™ kit, a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms.
EntroGen announces CE-IVD marking of its comprehensive Colorectal Cancer DNA panel and Thyroid Cancer kits
Today EntroGen Inc. announced CE-IVD marking of its Colorectal Cancer Panel (CRC), Thyroid Cancer Mutation Analysis kit (THDNA), and Thyroid Cancer Fusion Gene Detection kit (THRNA).
EntroGen releases BRCA Complete™ for targeted BRCA1/BRCA2 sequencing
Today EntroGen, Inc. has launched BRCA Complete™: a targeted next generation sequencing (NGS) panel for BRCA1 and BRCA2 exome sequencing on Illumina® MiniSeq, MiSeq, and NextSeq platforms.
EntroGen Launches Multiplexed Leukemia Translocation Panel
Today EntroGen (http://www.entrogen.com) announced immediate availability of its new Leukemia Translocation Panel—a multiplexed, one-step RT-PCR assay that detects eleven variants in 6 common leukemia-associated translocations simultaneously.
EntroGen announces immediate availability of its comprehensive Colorectal Cancer Mutation Detection Panel
October 3, 2016